je.st
news
Tag: teva
Allergan to acquire Naurex as Teva talks continue
2015-07-27 07:03:51| Biotech - Topix.net
Allergan PLC, the Dublin-based pharmaceutical giant, announced Sunday it has agreed to buy Naurex, a developer of drugs for depression and other central nervous system disorders, for $560 million. Naurex, based in Evanston, Illinois, is privately held.
Tags: continue
talks
acquire
teva
Teva nears deal for Allergan's generic drugs unit: Source
2015-07-26 18:24:45| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd is in advanced talks to buy Allergan Plc's generic drug business following a thus far unsuccessful effort to acquire peer Mylan NV , according to a person familiar with the matter. REUTERS: Teva Pharmaceutical Industries Ltd is in advanced talks to buy Allergan Plc's generic drug business following a thus far unsuccessful effort to acquire peer Mylan NV , according to a person familiar with the matter.
Mylan's independent foundation makes move to foil Teva
2015-07-23 17:24:31| Biotech - Topix.net
The Mylan NV saga has a new twist with a strategy underway to keep its would-be buyer Teva Pharmaceutical Industries at bay. Mylan's independent foundation in the Netherlands has exercised an option, called a stichting , to acquire shares that let it control half of the generic drugmaker.
Tags: makes
move
independent
foundation
U.S. consumer groups oppose Teva bid for generic drug rival Mylan
2015-07-14 21:13:30| Biotech - Topix.net
A proposed merger of the two largest U.S. generic drug makers drew fire on Tuesday from Consumers Union and seven other groups, who asked antitrust enforcers to stop Teva Pharmaceutical Industries Ltd's ( At this point, there is no deal. Mylan has been rebuffing Teva's takeover bids, including one in April for $40 billion.
Tags: groups
drug
consumer
bid
Teva plans to raise Mylan bid by as much as US$2 billion: Bloomberg
2015-07-06 23:49:48| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd is preparing to raise its bid for rival drugmaker Mylan NV by as much as US$2 billion, to US$43 billion, Bloomberg reported on Monday, citing people familiar with the matter. REUTERS: Teva Pharmaceutical Industries Ltd is preparing to raise its bid for rival drugmaker Mylan NV by as much as US$2 billion, to US$43 billion, Bloomberg reported on Monday, citing people familiar with the matter.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] next »